Le Lézard
Classified in: Science and technology, Business, Covid-19 virus
Subject: TNM

Chertoff Capital Advises Excivity in its Sale to AEgis Technologies, a Portfolio Company of Arlington Capital Partners


WASHINGTON, April 7, 2020 /PRNewswire-PRWeb/ -- Chertoff Capital LLC ("Chertoff Capital"), a wholly-owned subsidiary of The Chertoff Group, today announced that it served as the exclusive financial advisor to Excivity, Inc. ("Excivity" or the "Company"), a leading provider of mission-enabling technologies, including specialized security applications and situational awareness toolsets, in its recently announced acquisition by AEgis Technologies ("AEgis"), a portfolio company of Arlington Capital Partners ("ACP"). Headquartered in Chantilly, Virginia and founded in 2006, Excivity creates software and hardware, performs assessments and security reviews of technology, advises clients on how to securely implement technology, performs advanced cyber investigations and provides unique cyber security training to its diverse national security customer base.

Ryan Hoffman, managing director at Chertoff Capital, said: "Excivity is a highly specialized technology company with a truly mission-first culture. Excivity's shareholders sought a partner who shared their values and commitment to national security. As the first add-on acquisition to the AEgis platform, AEgis and ACP are an ideal fit. We congratulate Excivity and AEgis and look forward to supporting the combined company's continued success."

Matt Ramsey, CEO of Excivity, said: "Relationships and trust are key when forming a deal team and going through an acquisition process. I felt I made the right choice by selecting Chertoff Capital going into the process and knew I had made the right choice when the deal closed. There are so many nuances and perspectives to consider when putting your company and team in front of a buyer. Ryan and the Chertoff team were there as trusted advisors throughout the process."

Jason Kaufman, president of Chertoff Capital, added: "While everyone has been impacted by COVID-19, experienced deal professionals like Arlington Capital and AEgis are able to cut through the crisis to see long-term strategic opportunity. Excivity has scarcity value, proprietary technology solutions and an elite customer base. Companies with these attributes will continue to thrive during this period of uncertainty."

ABOUT EXCIVITY
Founded in 2006, Excivity creates and deploys mission-enabling technologies, including specialized security applications and situational awareness toolsets. The Company creates software and hardware, performs assessments and security reviews of technology, advises clients on how to securely implement technology, performs advanced Cyber Investigations, and provides unique Cyber Security Training to its diverse national security customer base. Excivity helps its customers successfully complete their missions by innovating, breaking, building, and teaching. https://excivity.com

ABOUT CHERTOFF CAPITAL LLC
Chertoff Capital is an industry leading investment bank serving high growth, mission-focused companies in the national security, information security, and government technology markets. As the investment banking subsidiary of The Chertoff Group, Chertoff Capital provides clients with a highly differentiated advisory offering that brings together transaction expertise with unparalleled business strategy insights. Chertoff Capital professionals have advised on well over 100 transactions over the last 20 years. https://www.chertoffgroup.com/    

ABOUT AEGIS TECHNOLOGIES
AEgis Technologies provides advanced engineering solutions across the space superiority, directed energy, missile defense, electronic warfare & cyber, C4ISR, and intelligence markets. The Company was founded in 1989 and has served its core customer base as a trusted partner for decades focused on solving the Defense and National Security Community's hardest challenges. AEgis is an end-to-end lifecycle partner from R&D, through development, and into operations. AEgis is the trusted provider leading the transformation for tomorrow's multi-model and multi-domain warfare.

ABOUT ARLINGTON CAPITAL PARTNERS
Arlington Capital Partners is a Washington, DC-based private equity firm that is currently investing out of Arlington Capital Partners V, L.P., a $1.7 billion fund. The firm has managed approximately $4.0 billion of committed capital via five investment funds. Arlington is focused on middle market investment opportunities in growth industries including government services and technology, aerospace & defense, healthcare, and business services and software. The firm's professionals and network have a unique combination of both operating and private equity experience that enables Arlington to be a value-added investor. Arlington invests in companies in partnership with high quality management teams that are motivated to establish and/or advance their Company's position as leading competitors in their field.

 

SOURCE Chertoff Capital


These press releases may also interest you

at 02:45
ASE Technology Holding Co., Ltd. (TWSE: 3711, NYSE: ASX) ("We", "ASEH", or the "Company"), the leading provider of semiconductor assembly and testing services ("ATM") and the provider of electronic manufacturing services ("EMS"), today reported its...

at 02:39
MYTILINEOS Energy & Metals (RIC: MYTr.AT) (Bloomberg: MYTIL.GA) announces its Q1 2024 financial results. 10% increase in Net Profit after minorities to ?158 million vs. ?143 million in Q1 2023. Earnings per Share came in at ?1.141, an increase of...

at 02:30
Allied Market Research published a report, titled, "Pension Administration Software Market by Component (Solution and Services), Deployment Mode (On-Premise and Cloud), Type (Public Pension and Private Pension), End User (Employers, Pension Plan...

at 02:26
Having consistently outperformed its targets and strategic goals, MYTILINEOS Energy & Metals ("MYTILINEOS") has initiated a review and evaluation of its strategic options, in consultation with its financial, legal and tax...

at 02:22
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...



News published on and distributed by: